Class IITerminated in FDA datasetRecall initiated Mar 23, 2017

PERFORMIX(TM) CREA-BEAD, MULTI-PHASE CREATINE, UNFLAVOURED, (a) 30 SERVINGS

Recalling firm: Armada Nutrition

Why it was recalled

A raw material initially failed testing Staphylococcus aureus. A retest was conducted with passing results but an out of specification investigation was not properly conducted…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Feb 14, 2018.

Check your package

Compare the exact product and package details with the label you have.

ProductPERFORMIX(TM) CREA-BEAD, MULTI-PHASE CREATINE, UNFLAVOURED, (a) 30 SERVINGS, UPC 8 11274 02239 8; (b) 45 SERVINGS, Distributed by Performix LLC, 221 S. Cherokee St., Denver, CO 80223, UPC 8 11274 02203 8
UPC811274022038

FDA code information

(a) lot IM458501, Exp 10/2018 (b) lot IM447128, Exp 07/2018, lot IM445515

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

PERFORMIX(TM) CREA-BEAD, MULTI-PHASE CREATINE, UNFLAVOURED, (a) 30 SERVINGS, UPC 8 11274 02239 8; (b) 45 SERVINGS, Distributed by Performix LLC, 221 S. Cherokee St., Denver, CO 80223, UPC 8 11274 02203 8

Extracted codes and context

TypeCode / valueContext
UPC811274022038INGS, Distributed by Performix LLC, 221 S. Cherokee St., Denver, CO 80223, UPC 8 11274 02203 8

Original FDA recall reason

A raw material initially failed testing Staphylococcus aureus. A retest was conducted with passing results but an out of specification investigation was not properly conducted leaving concern that the finished product could contain the bacterium.

Recall details

Recall number
F-2148-2017
Event ID
76825
FDA status
Terminated
Initiated
Mar 23, 2017
Reported
May 3, 2017
Classified
Apr 27, 2017
Terminated
Feb 14, 2018
Quantity
39,273 units
Location
Spring Hill, TN, United States
Initiation type
Voluntary: Firm initiated
Notification
Telephone

Where it was distributed

CO, NJ, England, South Africa,

FDA source record · F-2148-2017

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.